In this study, a new in vitro continuous colonic fermentation model of Salmonella infection with immobilized child fecal microbiota and Salmonella serovar Typhimurium was developed 30 for the proximal colon. This model was then used to test the effects of two amoxicillin concentrations (90 and 180 mg day -1 ) on microbial composition and metabolism of the gut microbiota and on Salmonella serovar Typhimurium during a 43-day fermentation. Addition of gel beads (2%, v/v) colonized with Salmonella serovar Typhimurium in the reactor resulted in a high and stable Salmonella concentration (log 7.5 cell number mL -1 ) in effluent samples 35 and a concomitant increase of Enterobacteriaeceae, Clostridium coccoides-Eubacterium rectale and Atopobium populations and a decrease of bifidobacteria. During amoxicillin treatments, Salmonella concentrations decreased while microbial balance and activity were modified in agreement with in vivo data with a marked decrease of Clostridium coccoides-Eubacterium rectale and an increase in Enterobacteriaceae. After interruption of antibiotic 40 addition, Salmonella concentration increased again to reach values comparable to that measured before antibiotic treatments, showing that our model can be used to simulate Salmonella shedding in children as observed in vivo. This in vitro model could be a useful tool for developing and testing new antimicrobials against enteropathogens.
Introduction 45
Salmonellosis is one of the most common and widely distributed foodborne diseases worldwide. It is associated with two types of symptoms, caused by different serovars of Salmonella enterica subsp. enterica: typhoid fever (mainly caused by serovar Typhi, Paratyphi and Sendai) which is more common in developing countries; and gastroenteritis (mainly caused by serovar Typhimurium and Enteritidis) also encountered in developed 50 countries (Coburn et al., 2007) . In Europe, 176,395 cases of salmonellosis infections (i.e. 38 for 100 000 habitants) have been declared in 2005, with a major proportion (20%) of young children less than 5 years of age (The European Food Safety Authority & European Center for Disease Prevention and Control, 2006) . In children, dehydration associated with diarrhea can become severe and life-threatening (Rosanova et al., 2002) , therefore effective antimicrobials 55 are essential drugs for treatment. Antimicrobials most widely regarded as optimal for treating diarrheal diseases caused by Salmonella serovar Typhimurium in children are third-generation cephalosporins, because quinolones and fluoroquinolones are generally not recommended due to their toxicity on immature cartilage and the possible emergence of resistant pathogens (Schaad, 2005) . The earlier drugs, chloramphenicol, amipicillin, amoxicillin and 60 trimethoprim-sulfamethaoxazole, are also used as alternatives (Frye & Fedorka-Cray, 2007; World Health Organization, 2008) . However, the emergence of Salmonella isolates with multiple-drug resistance urges the need for alternatives to antibiotherapies (White et al., 2001; World Health Organization, 2008) . Valuable models of Salmonella infection are therefore needed to develop and test new treatments, in particular for young human populations. 65
To our knowledge, there is currently no suitable model to test the effects of new antimicrobials on both enteropathogens and intestinal bacteria. Animal models, such as bovine or streptomycin-pretreated mice models for Salmonella infection do not reproduce the human intestinal microbiota and are dedicated for studying host-pathogen interactions -4 - (Hapfelmeier & Hardt, 2005) . Moreover, in vivo studies are difficult to perform due to cost, 70 ethical problems and high interindividual variations. By contrast, in vitro models are much less expensive, simpler to handle and could be a good alternative for testing new antimicrobial treatments in a first screening phase; but current models are not suitable for intestinal infections. The continuous culture models for human intestinal microbiota are mainly based on the original model of Macfarlane et al. (1998) and inoculated with diluted 75 feces. These systems have several limitations due to the planktonic state of bacterial populations, leading to limited microbial stability and cell density compared to the colon; they are also not suited for long-term experiments with enteropathogens since exogenous bacteria are rapidly washed out of the system (Blake et al., 2003; Carman et al., 2004; Carman & Woodburn, 2001; Payne et al., 2003) . Recently, we developed and validated a new model of 80 infant and adult colonic fermentation with fecal microbiota immobilized in gel beads in anaerobic continuous-flow cultures (Cinquin et al., 2006a; Cinquin et al., 2006b; Cleusix et al., 2008; Macfarlane & Macfarlane, 2007 ). This new model has conditions that are more akin to that of the intestinal system and has the following characteristics: bacteria growing in biofilm structures; high cell density in gel beads and in reactor effluents (up to 10 11 cells mL -1 85 or g -1 ); high stability and reactivity to changing conditions of the intestinal fermentation; good protection of sensitive bacteria from shear and oxygen stresses; and prevention of washout and loss of less competitive bacteria.
In this study we developed an in vitro model of intestinal fermentation with immobilized feces simulating intestinal Salmonella infections and long-term shedding in children. We 90 hypothesized that addition of colonized beads with Salmonella serovar Typhimurium in the intestinal fermentation model containing an immobilized child microbiota would cause a stable infection of Salmonella in gel beads and in effluent samples. The effect of two antibiotic treatments on Salmonella serovar Typhimurium, as well as on the main bacterial -5 -populations and metabolism of child's microbiota were tested during the same continuous 95 culture and compared with in vivo data to validate the model.
Materials and methods

Bacterial strain
Salmonella enterica subsp. enterica serovar Typhimurium M557 (sseD::aphT ∆invG) (S. Typhimurium) was supplied by Prof. W. Hardt (Institute of Microbiology, ETH, Zurich, 100 Switzerland). Sensitive to amoxicillin, this strain is a low virulent derivative of S.
Typhimurium wild-type strain SL1344 lacking SPI-1 effector proteins (Hapfelmeier et al., 2004) . It was routinely cultivated in tryptone soya broth (TSB, Oxoid, Basel, Switzerland) overnight at 37 °C in aerobiosis.
Antibiotic 105
In human practice, Clamoxyl ® /-RC (GlaxoSmithKline) containing amoxicillin as active compound, is a moderate-spectrum β-lactam antibiotic that can be used to treat salmonellosis in children (25-75 mg kg -1 day -1 ) (Moulin et al., 2003; Fachinformation des Arzneimittel-Kompendium der Schweiz ® , 2007) . It is bactericidal against a wide range of Gram-positive and Gram-negative bacteria, including sensitive Salmonella with minimum inhibitory 110 concentrations (MIC) ranging from 1 to 5 µg mL -1 for 90% of tested strains (Fachinformation des Arzneimittel-Kompendium der Schweiz ® , 2007). For the experiment, pure amoxicillin (Sigma-Aldrich, Buchs, Switzerland) was used.
Feces collection and bacterial immobilization
The fecal sample used for immobilization was collected from a healthy 2 year-old child, who 115 had not received antibiotics at least 3 months before the experiment. The fecal sample was maintained in anaerobiosis and immobilized in 1-2 mm gel beads composed of gellan (2.5%, -6 -w/v) and xanthan (0.25%, w/v) gums and sodium citrate (0.2%, w/v), as already described (Cleusix et al., 2008) . Gel beads (60 mL) were then transferred into a stirred glass reactor (Sixfors, Infors, Bottmingen, Switzerland) with 140 mL of fresh nutritive medium simulating 120 a child chyme (presented below). The entire process was completed under anaerobic conditions within 3 h after defecation.
S. Typhimurium immobilization was done one day before reactor inoculation using the same procedure as for fecal samples, but in aerobiosis under a sterile bench. Salmonella beads (10 mL) were colonized overnight in 200 mL TSB at 37 °C in aerobiosis without pH-control. 125 A fresh bead sample (0.5 g) was used to inoculate the reactor on day 11 and the rest was stored frozen (0.5 g aliquots) in 20% glycerol at -80 °C.
Nutritive medium
The nutritive medium used to feed the reactor was similar to that previously described by Macfarlane et al. (1998) for simulating an adult ileal chyme, with one modification; the bile 130 salt concentration was reduced from 0.4 to 0.05 g L -1 to reproduce the ileal chyme of a young child. A solution of vitamins described by Michel et al. (1998) and sterilized by filtration (Minisart 0.2 µm, Sartorius, Göttingen, Germany) was added (0.5 mL l -1 ) separately to the autoclaved (15 min, 121 °C) medium.
Experimental setup and sampling 135
A single-stage reactor based on the model described by Cinquin et al. (2004) was used to mimic the microbial ecosystem of a child's proximal colon. Batch fermentations were first carried out to colonize the fecal beads for 2 days. During colonization, the nutritive medium was aseptically replaced by fresh nutritive medium every 12 h. Temperature (37 °C) was automatically controlled and pH was maintained at 5.7 by adding NaOH (5N). Anaerobic 140 conditions were maintained during the whole fermentation by a continuous flow of pure CO 2 in the headspace. The continuous fermentation was carried out in the same reactor connected -7 -to a stirred feedstock vessel containing sterile nutritive medium continuously flushed with CO 2 and maintained at 4 °C and to an effluent receiving vessel. Continuous medium feeding was carried out using peristaltic pumps (Reglo analog, Ismatec, Glattbrugg, Switzerland) 145 delivering a feed flow rate of 40 mL h -1 for a mean retention time of 5 h. This time was used to simulate the residence time in a child proximal colon, with a pH of 5.7 (Fallingborg et al, 1990 ).
The 43-day continuous fermentation was divided into 6 periods of 5 to 9 days (Figure 1 ). First the system was stabilized (STyphi 0; days 3-10), then 0.5 g of beads colonized with 150 S. Typhimurium (days 11 and 13) were added to the system followed by a second stabilization period (STyphi I; days 14-20) and two antibiotic treatments (ATB I [214 µg mL -1 thrice a day]; days 21-25 and ATB II [428 µg mL -1 thrice a day]; days 35-39) intercalated with a third stabilization period without antibiotic (STyphi II, day 26-34). Amoxicillin was added directly in the reactor three times per day (at 9 a.m., 2 p.m. and 6 p.m.) to reach total concentrations of 155 90 mg day -1 (ATB I) and 180 mg day -1 (ATB II). According to the Fachinformation des Arzneimittel-Kompendium Schweiz ® , the average oral dose (divided into three doses) of Clamoxyl ® /-RC is 50 mg kg -1 day -1 for young children (2 to 12 year-old), with an absorption rate between 70 and 90% in the gastrointestinal tract. On the basis of two absorption rates of 70 and 85% we calculated that 90 to 180 mg day -1 amoxicillin should reach the colon for a 160 12 kg-child receiving 600 mg amoxicillin per day. On the last evening of ATB I (day 25) and II (day 39), the reactor was briefly stopped and the medium was entirely pumped out of the reactor after beads had settled. A new medium without antibiotic (Stab II and III) was immediately added. Effluent samples (10 mL) were collected daily for metabolites (shortchain fatty acids [SCFA], and lactate) and fluorescent in situ hybridization (FISH) analyses. 165
The pseudo-steady state for each period was reached when bacterial populations in the reactor -8 -effluent did not change by more than 0.5 log units during 4 consecutive days (Cinquin et al., 2006) .
During antibiotic treatments, effluent samples were collected before adding the first daily antibiotic dose. 170
Bacterial enumeration with FISH and microscopy
FISH analyses coupled with microscopy were performed for total bacteria and Salmonella enumeration as described by Cinquin et al. (2006a) on fermentation samples (1.5 mL) from the last 3 days of each pseudo-steady-state period. Total bacteria were stained with 4', 6diamidino-2-phenylindole (DAPI, Sigma-Aldrich, Buchs, Switzerland) and S. Typhimurium 175 was targeted with Sal 3, a Cy3-labelled oligonucleotide probe (Microsynth, Balgach, Switzerland) with hybridization conditions described by Nordentoft et al. (1997) .
Bacterial enumeration with FISH and flow cytometry
FISH analyses coupled with flow cytometry were performed based on the method described by Zoetendal et al. (2002) with some modifications. Briefly, 100 µL of fixed fermentation 180 samples (1.5 mL) and fixed feces (1.5 mL) were centrifuged (9000 g, 3 min) and the pellet was washed once in Tris-EDTA buffer (100 mM Tris/HCl, 500 mM EDTA, pH 8) before incubation for 10 min at room temperature in 100 µL of Tris-EDTA buffer supplemented with lysozyme (170'800 U mL -1 ) and proteinase K (6 µg mL -1 ) to destroy protein-clusters formed during both antibiotic treatment periods which interfered with flow cytometry detection. After 185 removing the lysozyme solution by centrifugation (9000 g, 3 min) and washing the pellet once with 100 µL of fresh hybridization buffer (900 mM NaCl, 20 mM Tris/HCl, 0.1% SDS, 30% formamide, pH 8), cells were resuspended in 300 µL of hybridization buffer, homogenized and divided into 10 aliquots of 25 µL. With exception of the negative control, aliquots were hybridized overnight at 35 °C with 50 ng µL -1 of Cy5-labeled probes (Table 1) . 190
Since hybridization conditions described for Sal 3 (Nordentoft et al., 1997) slightly differed -9 -from conditions used in flow cytometry, the Sal 3 probe specificity was tested again with hybridization conditions used for flow cytometry (Table 1) .
After hybridization and to remove non-specific binding of probes, 900 µL of warm washing buffer (64 mM NaCl, 20 mM Tris/HCl, 5 mM EDTA, 0.1% SDS, pH 8) was added and 195 samples were incubated at 37 °C for 20 min. A last centrifugation step was performed (9000 g, 3 min) before resuspending the pellet in 300 µL of cold potassium citrate buffer filter). The acquisition threshold was set in the forward scatter channel to the minimum. The flow rate was set at 1,000-3,000 events s -1 and 100,000 events were stored in list mode files.
Data were analyzed using the CXP software (Beckman Coulter International SA, Nyon, Switzerland). A PMT1 histogram (green fluorescence) was used to evaluate the total number of bacteria stained with SYBR Green I. In this histogram, a gate which included the total 215 number of bacterial cells in the sample was designed and used to make a PMT4 histogram -10 -(red fluorescence). This PMT4 histogram was then used to determine the bacterial groups marked with Cy5-labelled probes. To quantify bacterial groups and total cells, a correction was made to eliminate background fluorescence, measured using the negative control NON-EUB338-Cy5 probe, as described by Rigottier-Gois et al. (2003) . Analyses were done in 220 duplicate.
Metabolite analyses
SCFA (acetate, propionate, butyrate and formate) and lactate concentrations were determined by HPLC as previously described (Cleusix et al., 2008) . Each analysis was done in duplicate.
Mean metabolite concentrations were expressed in mM. 225
Statistical analyses
A one-way ANOVA was performed using SPSS 13.0 for Windows (SPSS Inc., Chicago, IL, USA) to test the effects of the different treatments on bacterial and metabolite concentrations measured during the pseudo-steady-state periods (mean of 3 successive days) in effluent samples. Treatment means were compared using the Tukey's test with the probability level of 230 P < 0.05. Data in the text are means ± SD.
Results
Microbial populations analyzed by FISH-flow cytometry
The child fecal sample used for immobilization showed a total population of 10.2 ± 0.1 log 10 cells g -1 , and was highly dominated by bifidobacteria (9.8 ± 0.1 log 10 cells g -1 ). Mean 235 concentrations of major bacterial populations measured in protease treated fermentation samples by FISH-Flow cytometry during the last three days of each experimental period are shown in Table 2 . The predominant bacterial genus in the reactor effluents during the whole fermentation (except during STyphi I) was Bifidobacterium spp., initially followed by -11 -
Clostridium coccoides-Eubacterium rectale and Bacteroides-Prevotella groups. No 240
Salmonella or other Enterobacteriaceae were detected during STyphi 0. Following addition of S. Typhimurium-colonized beads (11.1 log 10 cells (g bead) -1 ) to the reactor (days 11 and 13; STyphi I), a high concentration of Salmonella (7.5 ± 0.1 log 10 cells mL -1 ) was measured in effluent samples at the end of the first stabilization period (STyphi I, Table 2 ). Furthermore, the intestinal microbial balance largely changed compared with STyphi 0, with a significant 245 decrease of bifidobacteria (minus 1.2 log 10 unit) and a significant increase of Enterobacteriaceae, Atopobium spp. and the C. coccoides-E. rectale group. During this period (STyphi I), the C. coccoides-E. rectale group became the predominant bacterial group.
Addition of amoxicillin (90 mg day -1 , ATB I) induced a significant decrease in Salmonella concentration (more than 1.5 log 10 units) compared with STyphi I (Table 2 ) and a shift in the 250 different bacterial concentrations, which returned to values not significantly different from STyphi 0 (P > 0.05). The only exception was Enterobacteriaceae which in contrast to Salmonella, did not decrease during ATB I and remained significantly higher than during STyphi 0. During STyphi II with no antibiotic, most bacterial populations (including Salmonella) went back to values similar to STyphi I, except for Bifidobacterium spp. and C. 255 coccoides-E. rectale concentrations which were significantly higher and lower, respectively.
The second amoxicillin treatment (180 mg day -1 , ATB II) induced similar changes as during ATB I, but the effects on bacterial populations measured during the last three days were significant only for Salmonella and the C. coccoides-E. rectale group. Finally, during the last stabilization period without antibiotic (STyphi III), bacterial populations went back to values 260 similar to STyphi 0, except for Salmonella and total Enterobacteriaceae which remained significantly higher than for STyphi 0. No effect of treatments was observed on total bacteria or on Bacteroides concentrations during the whole fermentation.
Microbial populations analyzed by FISH-microscopy
Bacterial analyses with FISH coupled to microscopic counts for total bacteria and 265 S. Typhimurium used to monitor overtime the fermentation process corroborated data obtained with flow cytometry, with a significant decrease in Salmonella concentration during ATB I and II. No protease treatment was applied to these samples. However, a more pronounced inhibition of S. Typhimurium was measured with ATB I (minus 1.3 log 10 units compared with STyphi I) compared with ATB II (minus 0.95 log 10 units compared to 270 STyphi II) ( Figure 2 ). Furthermore cell aggregation was enhanced during antibiotic treatments. Total bacteria counts measured with FISH-microscopy were significantly lower (minus 1.2 log 10 units) than by FISH-flow cytometry, decreased from STyphi 0 to STyphi I and remained stable during the subsequent treatments.
Metabolites analyses 275
The profiles of metabolite concentrations during the different fermentation periods are shown in Figure 3 . Acetate was the main metabolite detected during STyphi 0 and throughout the fermentation (40-80 mM), whereas propionate and butyrate were present at low concentrations (≤ 20 mM). Lactate was also detected, although in variable concentrations (1-20 mM), during the whole fermentation. Addition of S. Typhimurium induced a significant 280 increase in butyrate (6.0 ± 0.1 and 13.5 ± 1.8 mM for STyphi 0 and STyphi I, respectively), whereas the other metabolites were not modified between the two periods ( (Table 3 ).
Discussion
Recently we successfully developed a new in vitro model of intestinal fermentation with immobilized fecal microbiota (Cinquin et al., 2004; Cinquin et al., 2006a; Cinquin et al., 2006b; Cleusix et al., 2008) . One major advantage of cell immobilization in intestinal 295 fermentation models is the very high microbial and metabolic stability due to entrapment and growth of fecal microbiota in polysaccharide beads, which was tested over long fermentation periods (up to 7 weeks).
In this study, we used the same approach with fecal sample immobilization and continuous fermentation to develop an original model simulating Salmonella gut infection in children. 300
We showed that cell immobilization can circumvent problems due to wash-out of exogenous enteropathogens observed in conventional in vitro intestinal fermentation models operated with planktonic cells (Blake et al., 2003; Carman et al., 2004; Payne et al., 2003) . According to our initial assumption, addition of S. Typhimurium immobilized in polysaccharide beads allowed to recover and maintain S. Typhimurium in the reactor effluents during the entire 305 fermentation of 43 days. Seven days after addition of S. Typhimurium colonized beads (days 18-20; STyphi I), the strain was detected at high concentrations (7.5 log 10 cells mL -1 ) in effluent samples, in agreement with in vivo concentrations of non-typhoid Salmonella shedding of up to 10 6 -10 7 organisms per gram of faeces measured in some children during early convalescence (Cruickshank & Humphrey, 1987) . A daily analysis of S. Typhimurium 310 and commensal bacteria was then performed in effluent samples. A protease treatment was used to destroy aggregates before bacterial enumeration with FISH-flow cytometry. However, no sample protease treatment was done before analysis with FISH-microscopy. Therefore the -14 -aggregation phenomena can explain the lower total and Salmonella cell counts detected with FISH-microscopy compared to FISH-flow cytometry. Furthermore the higher inhibition 315 effects of antibiotics on Salmonella detected with FISH-microscopy compared to FISH-flow cytometry can also be due to enhanced cell aggregation observed during antibiotic treatments.
Total bacteria and bifidobacteria populations measured during STyphi 0 and in feces were high and very close. Unfortunately, the other populations could not be determined in feces due to a lack of sample. We showed in previous studies that the main populations of child and 320 adult fecal samples were well preserved during immobilization and long-term continuous fermentation. However, differences of microbial balance between the fecal inoculum and reactor effluents occurred due to changes of environmental conditions between the host intestine and the fermentation model, such as medium composition, pH, and retention time (Cinquin et al., 2004; Cinquin et al., 2006b , Cleusix et al., 2008 . Such differences are often 325 observed with in vitro intestinal fermentation systems (Macfarlane & Macfarlane, 2007) .
Furthermore, conditions of the proximal colon applied in the fermentation model are very different to that of the distal colon where composition of fecal material is more akin to feces.
Compared with STyphi 0, S. Typhimurium colonization (STyphi I) induced a strong modification in the microbial balance. Bifidobacteria, present in high numbers during 330 STyphi 0 were significantly decreased, whereas C. cocoides-E. rectale group and Atopobium spp. were strongly increased (P < 0.05). In contrast to bacterial populations, metabolites were only slightly modified, with only a significant increase in butyrate concentrations during STyphi I. This butyrate accumulation may be explained by an increase in the C. cocoides-E. rectale group, which contains most of the butyrate producers (Barcenilla et al., 2000) . 335
As expected, addition of amoxicillin in the reactor significantly reduced S. Typhimurium concentration in effluent samples and changed the microbial balance. C. coccoides-E. rectale and Atopobium populations were strongly inhibited by amoxicillin, whereas Bacteroides, -15 -bifidobacteria and total Enterobacteriaceae were not affected. Marked decreases in the C.
cocoides-E. rectale group have already been described by Barc et al. (2004) in human fecal 340 flora-associated mice receiving amoxicillin-clavulanic acid (150 mg (kg of body weight) -1 ) for 7 days. The lack of activity of amoxicillin on Bacteroides-Prevotella and Enterobacteriaceae was also expected because it is known that certain Bacteroides such as Bacteroides fragilis and some Enterobacteriaceae (Klebsiella spp., E. coli) are not inhibited during amoxicillin treatments in humans (Sullivan et al., 2001; Floor et al., 1994) . Indeed, 345 resistance to β-lactams via β-lactamase production has been largely described in Bacteroides spp. and Enterobacteriaceae (Kader et al., 2004; Papaparaskevas et al., 2005) .
Unexpectedly, bifidobacteria were not inhibited by amoxicillin treatments and their growth was even stimulated during ATB I. Although it is generally admitted that bifidobacteria are highly sensitive to β-lactams (Moubareck et al., 2005) some strains are resistant to 350 amoxicillin (Lim et al., 1993; Vlková et al., 2006) . However, bifidobacteria overgrowth during ATB I may not be directly associated with the effects of antibiotics. It could also be due to the strong decrease in the C. coccoides-E. rectale group, which allowed the growth of bifidobacteria that came back to their previous concentrations (STyphi 0). It seems that bifidobacteria were particularly competitive in the system and that they prevented the 355 overgrowth of Bacteroides spp. during amoxicillin treatment, contrary to some in vivo observations (Christensson et al., 1991) . Enterobacteriaceae were not significantly decreased during ATB I, and ATB II despite a significant decrease of Salmonella, and became the second most dominant group during STyphi II, taking the place of the C. coccoides-E rectale group. Such increases in Enterobacteriaceae have also been frequently described in the 360 literature after amoxicillin treatments in humans (Christensson et al., 1991; Sullivan et al., 2001 ).
-16 -In parallel to modifications of microbial balance during ATB I and II, metabolite ratios were also strongly modified. ATB I decreased acetate and increased lactate and formate concentrations, whereas butyrate and propionate were not changed compared with STyphi I. 365
Doubling the amoxicillin concentration (ATB II) also led to a similar decrease in acetate concentration compared with STyphi II, but also to twice as much lactate and formate and to a decrease in propionate and butyrate concentrations. Lactate and formate are intermediate metabolites produced by many different bacteria (Cummings & Macfarlane, 1991) , further metabolised by other bacteria into CO 2 and major SCFA (acetate, propionate or butyrate) 370 (Duncan et al., 2004; Seeliger et al., 2002) . These metabolites generally do not accumulate in the human colon (Bernalier et al., 1999) . Their accumulation together with the changes in SCFA ratios during ABT I and II suggest that lactate-and formate-utilizing bacteria were inactivated during amoxicillin treatments. The marked decrease in the C. cocoides-E. rectale group, which harbours many lactate-utilizing bacteria (Duncan et al., 2004) is likely 375 responsible for lactate accumulation during these periods. Tables   Table 1 Oligonucleotide Nordentoft et al., 1997 *The oligonucleotide probe labelled at the 5' end with Cy-3 was detected with microscopy whereas Cy-5 labelled probes were used in flow cytometry. DAPI and SYBR Green I-stains were used for total bacteria enumeration in microscopy and flow cytometry, respectively. STyphi II, stabilization period; ATB II, second antibiotherapy, 180 mg day -1 ; STyphi III, stabilization period. Significance is based on last three days of each period. 
Figure legends
